Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-25 @ 3:44 AM
NCT ID:
NCT00229502
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of RRMS for at least one year,
* Currently on one of three immunomodulatory drugs (Avonex, Copaxone, or Rebif),
* Visual Acuity is 20/50 or better,
* patient has four color vision,
* Must have at least a high school education
Exclusion Criteria:
* History of head injury, drug/alcohol abuse, and/or psychiatric problems, -current diagnosis of a severe or lifethreatening disease other than MS,
* currently taking immunosuppressant medication,
* resides greater than 200 miles from the study site
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00229502
Study Brief:
Protocol Section:
NCT00229502